Protocol can minimize dose for CT scans when viral testing is less available.
Even though CT scans aren’t recommended for COVID-19 detection, radiologists still need a strategy for using the modality – and minimizing radiation dose exposure – for cases where other detection options aren’t readily available, according to industry experts.
To provide some guidance for imaging patients with suspected COVID-19 infection, a team of experts from the Iranian Society of Radiology, led by Mehran Arab-Ahmadi, M.D., MPH, outlined a strategy in Academic Radiology for imaging when there’s a shortage of the gold standard of testing, reverse transcriptase-polymerase chain reaction (RT-PCR).
“Low dose high-resolution CT might have more advantages than RT-PCR, especially in highly infected societies with low availability of PCR-kits,” the team wrote. “Our primary goal of screening and evaluation is to detect COVID-19 infection in patients with highly suspicious clinical conditions and laboratory findings.”
The Society developed a protocol for use with patients who have a high probability of COVID-19. It was created to work with all CT scanners with four or more detectors, the team said, and it’s defined for each manufacturer and model.
To find ground glass opacities in the typical sub-pleural location, the team made these suggestions:
Kvp: 100-120
mAs: 50-100
Pitch: 0.8-1.5
Thickness: 1-3 mm
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.